NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,309,677 | -59.8% | 1,504,991 | +3.0% | 0.00% | -57.1% |
| Q2 2023 | $60,517,423 | -28.1% | 1,460,529 | +4.2% | 0.01% | -36.4% |
| Q1 2023 | $84,196,633 | +85005.6% | 1,401,845 | +3.8% | 0.01% | -21.4% |
| Q4 2022 | $98,932 | -99.9% | 1,350,341 | +5.4% | 0.01% | -6.7% |
| Q3 2022 | $97,300,000 | +11.4% | 1,281,562 | +1.8% | 0.02% | +15.4% |
| Q2 2022 | $87,368,000 | -14.5% | 1,258,527 | +1.8% | 0.01% | 0.0% |
| Q1 2022 | $102,234,000 | +6.8% | 1,235,757 | -3.2% | 0.01% | +8.3% |
| Q4 2021 | $95,691,000 | -33.0% | 1,276,017 | +3.7% | 0.01% | -36.8% |
| Q3 2021 | $142,743,000 | -46.1% | 1,230,466 | +3.0% | 0.02% | -47.2% |
| Q2 2021 | $264,695,000 | +64.7% | 1,195,015 | -1.8% | 0.04% | +44.0% |
| Q1 2021 | $160,724,000 | -19.8% | 1,217,314 | +5.0% | 0.02% | -26.5% |
| Q4 2020 | $200,454,000 | +68.3% | 1,159,668 | +8.4% | 0.03% | +47.8% |
| Q3 2020 | $119,123,000 | +324.5% | 1,070,197 | +126.1% | 0.02% | +283.3% |
| Q2 2020 | $28,062,000 | -33.2% | 473,233 | -24.2% | 0.01% | -45.5% |
| Q1 2020 | $42,025,000 | -63.3% | 624,079 | -54.1% | 0.01% | -8.3% |
| Q4 2019 | $114,660,000 | +154.3% | 1,360,630 | +125.7% | 0.01% | +9.1% |
| Q3 2019 | $45,087,000 | +35.8% | 602,934 | +14.8% | 0.01% | +37.5% |
| Q2 2019 | $33,196,000 | +77.3% | 525,009 | +35.1% | 0.01% | +60.0% |
| Q1 2019 | $18,721,000 | -16.9% | 388,655 | -42.3% | 0.01% | +66.7% |
| Q4 2018 | $22,536,000 | +56.0% | 673,176 | +144.2% | 0.00% | -25.0% |
| Q3 2018 | $14,443,000 | +28.0% | 275,646 | -23.6% | 0.00% | +33.3% |
| Q2 2018 | $11,286,000 | +175.4% | 360,595 | +91.8% | 0.00% | +200.0% |
| Q1 2018 | $4,098,000 | +15.3% | 188,022 | +6.8% | 0.00% | 0.0% |
| Q4 2017 | $3,555,000 | +4.0% | 176,000 | +2.2% | 0.00% | 0.0% |
| Q3 2017 | $3,417,000 | +21.9% | 172,177 | +6.2% | 0.00% | 0.0% |
| Q2 2017 | $2,804,000 | +169.4% | 162,091 | +26.0% | 0.00% | – |
| Q1 2017 | $1,041,000 | +18.3% | 128,632 | +14.6% | 0.00% | – |
| Q4 2016 | $880,000 | +5.5% | 112,221 | +14.9% | 0.00% | – |
| Q3 2016 | $834,000 | -22.5% | 97,675 | +5.9% | 0.00% | -100.0% |
| Q2 2016 | $1,076,000 | +82.4% | 92,247 | +126.3% | 0.00% | – |
| Q1 2016 | $590,000 | -31.9% | 40,771 | +5.1% | 0.00% | – |
| Q4 2015 | $867,000 | – | 38,783 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |